Kimberly Wehger
Chief Tech/Sci/R&D Officer chez ARVINAS, INC.
Profil
Kimberly Wehger est vice-présidente des technologies de l'information chez Arvinas, Inc. Dans le passé, Mme Wehger a été directrice des technologies de l'information et vice-présidente de New Haven Pharmaceuticals, Inc, directrice de l'engagement commercial d'Alexion Pharmaceuticals, Inc et directrice de la pratique des services gérés de R&D chez Veeva Systems, Inc. Elle a obtenu un diplôme de premier cycle à l'Université d'État de New York à Binghamton et un diplôme d'études supérieures à l'Université d'État du Connecticut du Sud.
Postes actifs de Kimberly Wehger
| Sociétés | Poste | Début |
|---|---|---|
| ARVINAS, INC. | Chief Tech/Sci/R&D Officer | - |
Anciens postes connus de Kimberly Wehger
| Sociétés | Poste | Fin |
|---|---|---|
New Haven Pharmaceuticals, Inc.
 New Haven Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology New Haven Pharmaceuticals, Inc. develops new prescription drug products. It developes proprietary prescription pharmaceuticals that utilize currently marketed drugs or generally recognized as safe (GRAS) active pharmaceutical ingredients (APIs) for use in therapeutic applications. The company was founded by Harry H. Penner Jr. in 2008 and is headquartered in Branford, CT. | Chief Tech/Sci/R&D Officer | 01/01/2016 |
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
| VEEVA SYSTEMS INC. | Corporate Officer/Principal | - |
Formation de Kimberly Wehger
| Southern Connecticut State University | Graduate Degree |
| State University of New York at Binghamton | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| VEEVA SYSTEMS INC. | Technology Services |
| ARVINAS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
New Haven Pharmaceuticals, Inc.
New Haven Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology New Haven Pharmaceuticals, Inc. develops new prescription drug products. It developes proprietary prescription pharmaceuticals that utilize currently marketed drugs or generally recognized as safe (GRAS) active pharmaceutical ingredients (APIs) for use in therapeutic applications. The company was founded by Harry H. Penner Jr. in 2008 and is headquartered in Branford, CT. | Health Technology |
